James R. Cavey
- Molecular Biology
- Oncology top 10%
- Epidemiology top 10%
- Cell Biology top 10%
- Neurology top 10%
- Co-authors
- Robert LayfieldMark S. SearlePaul W. SheppardStuart H. RalstonBarbara CianiJed LongJames LoweLynne J. Hocking
- Topics
- Ubiquitin and proteasome pathways (11 papers)Cancer-related Molecular Pathways (8 papers)Bone health and treatments (4 papers)
- Cited by
- OncologyEpidemiologyNeurology
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
James R. Cavey
16 papers receiving 900 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 558
- Oncology 360
- Epidemiology 299
- Cell Biology 133
- Neurology 129
Countries citing papers authored by James R. Cavey
This map shows the geographic impact of James R. Cavey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Cavey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Cavey more than expected).
Fields of papers citing papers by James R. Cavey
This network shows the impact of papers produced by James R. Cavey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Cavey. The network helps show where James R. Cavey may publish in the future.
Co-authorship network of co-authors of James R. Cavey
This figure shows the co-authorship network connecting the top 25 collaborators of James R. Cavey. A scholar is included among the top collaborators of James R. Cavey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Cavey. James R. Cavey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 116 | |
| 3 | 4 | |
| 4 | 15 | |
| 5 | 28 | |
| 6 | 12 | |
| 7 | 34 | |
| 8 | 44 | |
| 9 | 128 | |
| 10 | 63 | |
| 11 | 22 | |
| 12 | 94 | |
| 13 | 27 | |
| 14 | 124 | |
| 15 | 87 | |
| 16 | 108 |
About James R. Cavey
James R. Cavey is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 16 papers that have together received 910 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (11 papers), Cancer-related Molecular Pathways (8 papers) and Bone health and treatments (4 papers). The work is most often cited by research in Oncology (360 citations), Epidemiology (299 citations) and Neurology (129 citations). James R. Cavey has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Robert Layfield, Mark S. Searle, Paul W. Sheppard, Stuart H. Ralston, Barbara Ciani, Jed Long, James Lowe, Lynne J. Hocking, Barry Shaw and Daniel Scott. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.